Skip to main content
. Author manuscript; available in PMC: 2009 Oct 1.
Published in final edited form as: Neuropharmacology. 2008 Jun 7;55(5):687–692. doi: 10.1016/j.neuropharm.2008.06.001

Figure 4.

Figure 4

Western blots using 5-HT2A Receptor Antibodies. (A) A representative western blot of 5-HT2A receptor protein levels in the PVN of rats treated with DOI for 7 days (DOI7) or saline for 7 days. (B) 5-HT2A receptor protein levels were significantly increased in the rats treated with DOI for 4 and 7 days compared to saline-treated rats (p<0.05).